Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: The influence of depression and anxiety

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 7, 2008, Pages 561-571

  Haag, S ^b   Senf, W ^b   Hauser W ^c   Tagay, S ^b   Grandt, D ^c   Heuft, G ^d   Gerken, G ^b   Talley, N J ^e,f   Holtmann, G ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c KLINIKUM SAARBRÜCKEN   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC LIVER DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; DYSPEPSIA; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36;

ADULT; ANXIETY DISORDERS; CHRONIC DISEASE; DEPRESSIVE DISORDER; DYSPEPSIA; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 39849090030     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03619.x     Document Type: Article

References (52)

1. Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 2004 13: 283 98.
2. Knight M, Stewart-Brown S, Fletcher L. Estimating health needs: the impact of a checklist of conditions and quality of life measurement on health information derived from community surveys. J Public Health Med 2001 23: 179 86.
3. Avis N, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol 2005 23: 3322 50.
4. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981 305: 982 7.
5. Younossi ZM, Guyatt G. Quality-of-life assessments and chronic liver disease. Am J Gastroenterol 1998 93: 1037 41.
6. Bergner M. Quality of life, health status, and clinical research. Med Care 1989 27: S148 56.
7. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996 334: 835 40.
8. Agreus L. The epidemiology of functional gastrointestinal disorders. Eur J Surg Suppl 1998 583: 60 6.
9. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002 97: 2290 9.
10. Locke GR. The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996 25: 1 19.
11. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999 45 (Suppl. 2 II37 42.
12. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995 109: 1736 41.
13. Moore R, Mao Y, Zhang J, et al. Economic Burden of Illness in Canada 1993. Ottawa, Canada: Authority of the Minister of Health, Minister of Public Works and Government Services, 1997.
14. Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut 2002 50 (Suppl. 4 iv10 2.
15. Mones J, Adan A, Segu JL, Lopez JS, Artes M, Guerrero T. Quality of life in functional dyspepsia. Dig Dis Sci 2002 47: 20 6.
16. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995 40: 584 9.
17. Akehurst RL, Brazier JE, Mathers N, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002 20: 455 62.
18. Creed F, Ratcliffe J, Fernandez L, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001 134: 860 8.
19. Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005 11: S17 26.
20. Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002 24: 675 89.
21. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000 119: 654 60.
22. Talley NJ, Locke GR III., Lahr B, et al. Functional dyspepsia, delayed gastric emptying and impaired quality of life. Gut 2006 55: 933 9.
23. Jones MP, Sharp LK, Crowell MD. Psychosocial correlates of symptoms in functional dyspepsia. Clin Gastroenterol Hepatol 2005 3: 521 8.
24. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994 20: 1442 9.
25. Angelini F, Nassuato G, Okolicsanji L, Toso S, Corbetti F, Zacchi C. The prevalence of diffuse and focal lesions of the hepatic parenchyma in a nonselected, resident population. A prospective echographic study. Radiol Med (Torino) 1990 79: 470 3.
26. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987 7: 122 8.
27. Hauser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004 2: 157 63.
28. Conn H, Lieberthal M. The Hepatic Coma Syndromes and Lactulose. Baltimore: Williams & Wilkins, 1979: 46 84.
29. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003 52: 879 85.
30. Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999 45: 295 300.
31. Hauser W, Zimmer C, Schiedermaier P, Grandt D. Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C. Psychosom Med 2004 66: 954 8.
32. Spiegel BM, Gralnek IM, Bolus R, et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004 164: 1773 80.
33. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973 60: 646 9.
34. Talley NJ, Phillips SF, Bruce B, Zinsmeister AR, Wittgen C, Melton LJI. Multisystem complaints in patients with the irritable bowel syndrome and functional dyspepsia. Eur J Gastroenterol Hepatol 1991 3: 71 7.
35. Talley NJ, Phillips SF, Melton J III., Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989 111: 671 4.
36. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994 39: 1090 8.
37. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999 45 (Suppl. 2 II1 5.
38. Ware JE Jr. SF-36 Health Survey. Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.
39. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung. Göttingen: Hogrefe, 1998.
40. Unal G, de Boer JB, Borsboom GJ, Brouwer JT, Essink-Bot M, de Man RA. A psychometric comparison of health-related quality of life measures in chronic liver disease. J Clin Epidemiol 2001 54: 587 96.
41. Kuykendall DH, Rabeneck L, Campbell CJ, Wray NP. Dyspepsia: how should we measure it? J Clin Epidemiol 1998 51: 99 106.
42. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998 12: 1067 78.
43. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67: 361 70.
44. Herrmann C, Buss U, Snaith RP. HADS-S: Hospital Anxiety and Depression Scale - Deutsche Version. Bern: Hans Huber, 1995.
45. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997 42: 17 41.
46. El Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003 18: 387 93.
47. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998 27: 209 12.
48. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001 96: 2737 44.
49. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999 11: 833 8.
50. Piche T, Gelsi E, Schneider SM, et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 2002 51: 434 9.
51. Whitehead WE, Bosmajian L, Zorderman AB, Costa PT, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988 95: 709 14.
52. Jones MP, Sharp LK, Crowell MD. Psychosocial correlates of symptoms in functional dyspepsia. Clin Gastroenterol Hepatol 2005 3: 521 8.